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Hypocalcaemia is a complication of parathyroidectomy.We retrospectively analyzed data on patients
who underwent parathyroidectomy for primary hyperparathyroidism (pHPT) to identify predictive
factors for severe postoperative hypocalcaemia. Since 2004 we performed 87 parathyroidectomies for
pHPT. We divided the patients into two groups: subjects who presented with postoperative hypo-
calcaemia (group B) or otherwise (group A). We looked for a correlation between several variables
and the incidence of postoperative hypocalcaemia. Themedian calcemia in group B (19 patients) was
6.9 mg/dL on the first postoperative day and 7.6 mg/dL on the third day. We observed hypocalcemia
related clinical symptoms in every patient. In all 19 cases the reduction of intraoperative parathyroid
hormone above 85 per cent after parathyroidectomy was related to the development of severe
postoperative hypocalcaemia (P 5 0.042). We found that the reduction of intraoperative parathyroid
hormone over 85 per cent after parathyroidectomy can be considered a reliable predictive factor of
postoperative hypocalcaemia after parathyroidectomy for primary hyperparathyroidism.
P RIMARY HYPERPARATHYROIDISM (pHPT) is an in-creasingly common endocrine disorder with a
higher incidence between the fifth and seventh decade
of life.1–9 In more than 70 per cent of cases it is due to
single adenomas whereas in 10 to 20 per cent of cases it
is caused by multiglandular disease, like double ade-
nomas or hyperplasia,1, 2, 5, 10–14 and it is rarely sec-
ondary to parathyroid cancer.1, 2, 10, 11, 15, 16
Over the years many different therapeutic approaches
have been proposed to treat pHPT and, among all
these, parathyroidectomy represents a mainstay in case
of symptomatic pHPT, with a percentage of success over
95 per cent. It is also indicated in selected asymptomatic
patients.17–23 It has been demonstrated that patients who
underwent parathyroidectomy have a lower risk of mor-
tality, onset of cardiovascular complications, and even
pHPT-related tumors than patients who were not op-
erated.1, 2, 6, 24–30 However, parathyroidectomy can be
followed by life-threatening perioperative complications
such as severe hypocalcaemia.31–44 The incidence of
transient postoperative hypocalcaemia rates from 0 per
cent to 35 per cent,36–46 whereas a permanent hypo-
calcaemia occurs in 0 per cent to 3.8 per cent of cases.45–48
At present, no specific causes have been disclosed to
explain the onset of postoperative hypocalcaemia that
still remains a postparathyroidectomy multifactorial
syndrome.36–39, 49 Moreover, this syndrome has an im-
portant role in the postoperative management of patients
who underwent parathyroidectomy because in case
of severe hypocalcaemia a longer clinical observation
and hospital stay associated to a supplementation of
calcium and Vitamin D are required. In this light, the
identification of predictive factors for the development
of postoperative hypocalcaemia would be beneficial;
this would allow surgeons to select patient candidates
for parathyroidectomy on an outpatient or a short-stay
basis.36, 37, 39, 40, 44, 45, 47, 48
This study aimed to identify possible predictive fac-
tors for the onset of postoperative hypocalcaemia after
parathyroidectomy for pHPT.
Patients and Methods
We retrospectively analyzed the data of 87 patients
undergoing surgery for pHPT between June 2004 and
December 2009. For all these patients we considered
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gender, age, symptoms experienced, symptom-diagnosis
latency, and any previous neck surgery. We recorded the
data of perioperative laboratory tests, specifically serum
concentration of calcium, parathyroid hormone (PTH),
alkaline phosphatase (AP), creatinine, magnesium, po-
tassium, bicarbonates, phosphates, albumin, and serum
pH value. We evaluated the reduction in intraoperative
PTH (i.o. PTH) expressed as a percentage defined using
the following formula: [(PTH at induction – i.o. PTH
after 10 minutes from the parathyroidectomy)/ PTH at
induction] 3 100.
Quick i.o. PTH was determined using a solid-phase
chemiluminescent immunometric assay (Immulite Ana-
lyser Turbo Intact PTH, Medical System, Genoa, Italy).
All the blood samples were taken from peripheral veins.
We also recorded the results of the histological ex-
amination, with particular reference to the weight of
the parathyroid adenoma, postoperative calcaemia, the
presence of any hypocalcaemia-induced clinical symp-
toms (paraesthesia, cramps, Chvostek sign, Trousseau
sign), and the duration of the hospital stay.
We defined postoperative hypocalcaemia as a serum
calcium level < 8 mg/dL in one measurement recorded
within 4 days of the parathyroidectomy.50 Severe hy-
pocalcemia was defined as serum calcium levels below
7.5 mg/dL.
We looked for statistical correlation between the
variables considered and the incidence of postoperative
severe hypocalcaemia by splitting the subjects into two
groups: patients who did not present postoperative se-
vere hypocalcaemia (group A) and patients who expe-
rienced such complication (group B).
We scheduled follow-up with clinical and biochemical
examinations 1 week and 1, 6, and 12 months after sur-
gery. At each follow-up meeting we recorded serum
calcium, Vitamin D, and PTH values, and vitamin D
metabolic complications. The mean follow-up was
12.6 months (range 18.7–10.0 months) to identify the
onset of any recurrent or persistent pHPT.
Statistical Analysis
Chi-squared or Fisher’s exact tests were used when
appropriate to compare categorical variables; logistic
regression models were used in univariate and multi-
variate analyses to identify the factors related to post
operative severe hypocalcemia. For each analysis the
following potential predictive variables were taken
into account: age, gender, previous neck surgery (yes/
no), preoperative serum calcium, PTH, AP, creatinine,
magnesium, potassium, bicarbonates, phosphates, al-
bumin concentration, the weight of the parathyroid
adenoma, and the reduction of i.o. PTH.
Finally, Receiver Operating Characteristic (ROC)
curves were constructed when appropriate. The level
of statistical significance was set at P < 0.05. All tests
were two-sided. Statistical analysis was performed with
statistical software for biomedical research (MedCalc
Software for Windows, Version 9.2.0.0, MedCalc Soft-
ware, Mariakerke, Belgium).
Results
The median age of the patients studied (61 female and
26 male) was 63.9 years. Among all the 87 subjects, 68
(78.2%) did not present severe hypocalcemia after
parathyroidectomy (group A), whereas 19 patients suf-
fered from severe postoperative (PO) hypocalcemia with
serum calcium level lower than 7.5 mg/dL. Table 1 in-
dicates the characteristics of the two groups of patients
considered.
Group A
The median age among group A (49 females and 19
males) was 62.3 years (range 29–78 years). Overall,
the preoperative clinical manifestation of pHPT were:
renal in 33 cases (48.5%); 18 patients (26.5%) had bone
alterations, 8 patients (11.8%) suffered neurological
and/or mental disorders, and 17.4 per cent of patients (12
cases) were asymptomatic. Symptom-diagnosis latency
varied from 3 to 54 months. Eleven patients (16.2%)
were on chronic therapy with diuretics and two pa-
tients (2.9%) were on calcium antagonists.
Preoperative hypercalcemia was present in all pa-
tients (100%), with median values of 13.1 mg/dL (range
10.1–19.8 mg/dL) and in 10 cases (14.7%) alkaline
phosphatase was elevated. No patient had low albumin
values or serum pH alterations. All patients (100%) had
preoperative PTH values above the normal range: me-
dian value 410 (range 97–1450 pg/mL). A single para-
thyroidectomy was performed in 61 cases (89.7%).
The histological examination showed the presence
of a parathyroid adenoma in all cases (100%). The me-
dian weight of the adenoma was 550 milligrams (range
TABLE 1. Characteristics of Patients Undergoing
Parathyroidectomy for Primary Hyperparathyroidism
According to the Presentation of Postoperative Hypocalcaemia
(Group B) or Otherwise (Group A)
Variable Group A Group B
Mean age 62.3 years 66.4 years
F/M gender ratio 2.6 1.7
Preoperative Ca+ 13.1 mg/dL 12.3 mg/dL
Ca+ 1st postoperative day 8.5 mg/dL 6.9 mg/dL
Ca+ 3rd postoperative day 8.7 mg/dL 7.6 mg/dL
Preoperative PTH 410 pg/mL 390 pg/mL
Change i.o. PTH %
10 minutes
77.0% 89.7%
Weight of the adenoma 550 grams 635 grams
Data are given as a median ± standard deviation unless other-
wise indicated.
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360–1800 milligrams). The i.o. PTH level measured at
the induction of anesthesia and 10 minutes from the
parathyroidectomy revealed a median drop of 77 per
cent (range 65–88%).
In the first and third postoperative days, none of the
patients had median calcaemia values lower than normal
range (8.5 mg/dL, range 8.3–9.0 mg/dL and 8.7 mg/dL,
range 8.6–9.3 mg/dL, respectively) and none presented
any clinical symptoms of hypocalcaemia. The pre and
postoperative values of serum creatinine, phosphate,
magnesium, potassium, bicarbonate, and pH were also
found to be normal. No calcium and vitamin D supplies
were administered. Median time for discharge was 3.5
days (range 3.0–4.5) and none of the patients presented
persistent or recurrent pHPT at follow-up controls.
Group B
The median age in group B (12 females and 7 males)
was 66.4 years (range 35–74 years). Nine patients out
of the 19 presented preoperatively with renal symptoms;
bone alterations were observed in five cases (26.3%)
and 2 patients (16.7%) had neurological and/or mental
disorders, whereas 3 patients were asymptomatic.
Symptom-diagnosis latency varied from 3 to 48months.
Two patients (10.5%) were on chronic therapy with
diuretics, 1 patient (5.3%) was on angiotensin converting
enzyme (ACE) inhibitors, and 1 patient (5.3%), digitalis
therapy. Blood examinations revealed a median serum
calcium value of 12.3 mg/dL (range 10.8–20 mg/dL),
preoperative alkaline phosphatase was elevated in 3
patients (15.8%), and serum pH and albumin values
were within the normal range. All patients had a pre-
operative PTH value above the normal range: median
value 390 pg/mL (range 91–1600 pg/mL). None of the
patients had had previous neck surgery. Sixteen pa-
tients (84.2%) underwent simple parathyroidectomy.
The histological response in all cases demonstrated
the presence of an adenoma, with a median weight of
635 milligrams(range 400–1650 milligrams). The mean
reduction in i.o. PTHwas 89.7 per cent (range 86–97.5%).
The median serum calcium value on the first post-
operative day was 6.9 mg/dL (range 6.3–7.4 mg/dL) and
on the third postoperative day it was 7.6 mg/dL (range
6.8–7.8 mg/dL). The pre and postoperative values of
serum creatinine, phosphate, magnesium, potassium,
bicarbonate, and pH were within normal range.
All patients presented hypocalcaemia-related clinical
symptoms, paraesthesia, cramps, Chvostek sign, and
Trousseau sign, and were administered with parenteral
and/or oral calcium and vitamin D until their calcae-
mia values normalized and the hypocalcaemia-related
symptoms had disappeared. Patients were discharged
when their serum calcium level was higher than 8 mg/
dL. Median time to discharge was 5.5 days (range 6.0–
8.5 days). All patients had normal calcemia values
6 months from the procedure. None of the patients
presented with persistent hypoparathyroidism or per-
sistent or recurrent pHTP at each follow-up meeting.
Risk Factors For Postoperative Severe Hypocalcemia
At univariate analysis, only i.o. PTH reduction was
found to be predictive of postoperative severe hypocal-
cemia. Conversely, preoperative serum PTH and calcium
levels, as well as patients’ gender, age, parathyroid ade-
noma weight, previous neck surgery, surgical approach,
AP, creatinine, magnesium, potassium, bicarbonate,
and albumin serum concentration were not significantly
correlated to postoperative severe hypocalcemia.
Significantly, at multivariate analysis, the i.o. PTH
reduction was confirmed as independent risk factor for
postoperative severe hypocalcemia (Table 2).
The ROC-curve analysis for intraoperative reduction
showed a significant area under the curve (Fig. 1). In
particular, i.o. PTH reduction as high as 85 per cent was
found to be the most reliable cut-off for postoperative
severe hypocalcemia (odds ratio 93, 95%confidence
interval 11 to 773, P4 0.0001).
Discussion
Postoperative hypocalcaemia is one of the most im-
portant and potentially most dangerous complications of
TABLE 2. Univariate and Multivariate Analyses of Risk
Factors of Severe Postoperative Hypocalcemia
Independent
Variables
Univariate
Analysis
P-value
Multivariate
Analysis
P-value
Preoperative serum
PTH level
0.8 —
Preoperative serum
calcium level
0.57 —
i.o. PTH level <0.0001 0.042
Preoperative K+ serum level 0.76 —
Preoperative Na+ serum level 0.65 —
Preoperative PA serum level 0.55 —
Preoperative creatinine
serum level
0.82 —
Preoperative
Mg++ serum level
0.75 —
Preoperative albuminemia 0.45 —
Operative time 0.6 —
Surgical approach (unilateral/
bilateral neck exploration)
0.44 —
Parathyroid adenoma weight 0.31 —
Gender 0.57 —
Age 0.45 —
Previous neck surgery 0.77 —
Of all the variables tested in univariate analysis, only those
with P values# 0.05 were entered into multivariate analyses in
a stepwise manner until all variables remaining in the model
were significant.
PA, alkaline phosphate.
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parathyroidectomy, with a multifactorial pathogenesis.36–55
We considered severe hypocalcaemia as postoperative
serum calcium level < 7.5 mg/dL. A possible cause of
temporary or permanent symptomatic hypoparathyroid-
ism is parathyroid gland damage, which can be caused
by inadvertent removal of parathyroid tissue, but is more
commonly caused by devascularization because the
blood supply to the parathyroid glands from the inferior
thyroid artery is limited and sensitive to surgical ma-
nipulation; other factors include direct trauma to the
parathyroid gland causing haematoma.37, 38, 45, 51
Many authors have reported a significant reduc-
tion in the incidence of postparathyroidectomy hypo-
calcaemia by performing a unilateral exploration in
cases of pHPT.38, 52, 53, 55 Moreover the onset of hypo-
calcaemia could be dependent from calcitonin hyper-
incretion, due to thyroid manipulation, and perioperative
calcium hemodilution.37, 49 The main mechanism is
probably the inadequate parathyroid function caused by
a slow or delayed functional recovery of the residual
parathyroid tissue after hyper-functioning adenoma re-
moval.46, 54 Post-parathyroidectomy hypocalcaemia can
also be caused by a rapid recovery of calcium uptake by
the skeleton (hungry bone syndrome).45
Temporary hypocalcaemia has been reported to
occur in 0 per cent to 35 per cent of patients after
parathyroidectomy, whereas permanent hypoparathy-
roidism occurs after parathyroidectomy in 0 per cent to
3.8 per cent of cases.1, 36, 38, 43, 45, 46 In our experience
the incidence of temporary postparathyroidectomy
hypocalcaemia was 21.8 per cent (19/87 patients).
Higher incidences of temporary and permanent hypo-
calcaemia (> 40%) are recorded in patients undergoing
repeated surgery for persistent or recurrent pHPT.47, 48
A significant drop in calcium is often not evident until
the third or fourth postoperative days.37
Symptomatic hypocalcaemia plays an important role
in delaying hospital discharge, and for this reason sev-
eral surgeons advocate routine postoperative supple-
mentation with calcium or vitamin D to facilitate early
discharge.43, 49, 56 Several studies tried to identify fac-
tors that can predict the onset of postparathyroidectomy
hypocalcaemia.36, 37, 39, 40, 43–45, 47, 48 Those patients
who can be identified as being low risk for develop-
ing postoperative hypocalcaemia can conceivably be
treated on an outpatient or short-stay basis, which
would result in considerable reductions in health-
care costs. Only selected cases require replacement
therapy, and overtreatment may inhibit parathyroid
function.36, 37, 39, 40, 43–45, 47, 48
Multivariate analysis of clinical and biochemical data
including patients’ gender and age, symptoms, symptom-
diagnosis latency, preoperative calcaemia, the preoper-
ative PTH value and reduction in i.o. PTH, preoperative
alkaline phosphatase, the weight of the gland removed,
cardiac medications, and the type (mono or bilateral
exploration) and duration of the surgical procedure have
all been shown to be associated with the risk of post-
operative hypocalcaemia.36, 37, 39, 40, 44, 45, 47, 48, 52–55
The demographic characteristics of our patients, their
symptoms, and symptom-diagnosis latency were not
related with the onset of postoperative hypocalcaemia,
as reported in other studies.37, 39
In contrast with the findings reported by Westerdahl
et al.,37 in our patients, postoperative symptomatic
hypocalcaemia was not related with preoperative serum
levels of calcitonin and alkaline phosphatase. Some
authors36, 37 report that preoperative normocalcaemia
was associated with an increased risk of postoperative
hypocalcaemia. This was not confirmed in our study.
There is usually a discrete correlation between the
mass of the adenoma and the amount of parathyroid
hormone secreted.57 By contrast the weight of the ade-
noma does not represent a predictive factor for the onset
of postoperative hypocalcaemia, as reported in the lit-
erature36 and by our experience.
Kald et al.39 reported that a high preoperative PTH
value (five times the upper limit of normal) represents
a risk factor for the onset of postoperative hypocalcaemia
FIG. 1. ROC-curve analysis. Variable: i.o. PTH drop. Outcome:
severe postoperative hypocalcemia.
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(41%), whereas only 6 per cent of patients with preop-
erative PTH values within normal range (<35 pmol/L)
developed postparathyroidectomy hypocalcaemia. We
did not observe statistically significant correlation
between preoperative PTH values and the onset of
postoperative hypocalcaemia.
The i.o. PTH assay has been widely used for predicting
removal of hyperfunctioning parathyroid tissue.48, 58, 60
Although the pathogenesis of postoperative hypo-
calcaemia is multifactorial,36–39, 45, 46, 49, 52–55 impaired
parathyroid function is likely the main contributing
factor for clinical hypocalcaemia. Many studies have
reported the utility of the quick i.o. PTH assay in pre-
dicting postthyroidectomy hypocalcaemia,45, 49, 50, 61
but its value in parathyroid surgery has not been well
established.36, 44, 47, 48, 59 A significant reduction in i.o.
PTH, higher than or equal to 80 per cent has been reported
to represent a positive predictive value for identifying
patients who develop postparathyroidectomy hypo-
calcaemia and who will require support treatment with
postoperative calcium and vitamin D.36, 37, 44, 47, 48, 59
In our experience, i.o. PTH reduction was found at
multivariate analysis to be the only predicting factor
for postoperative severe hypocalcemia. Furthermore,
ROC-curve analysis revealed that i.o. PTH reduction
greater than 85 per cent is strongly and positively re-
lated to the development of severe postoperative hy-
pocalcemia, with odds ratio as high as 93. We did not
record any other statistically significant relationship
with the absolute values of i.o. PTH at induction and 10
minutes after parathyroidectomy.
Some studies comparing unilateral with bilateral
cervical exploration found an increased incidence of
hypocalcaemia and significantly lower postopera-
tive calcium levels in patients undergoing bilateral
exploration.38, 52, 53, 55 However, we did not find any
relationship between the type of surgery performed
(uni- or bilateral cervical exploration) associated with
thyroid surgery and duration of the procedure with the
onset of postoperative hypocalcaemia.
Conclusions
Our study showed that, among all the parameters
analyzed, only reduction of i.o. PTH greater than 85 per
cent after parathyroidectomy can be considered as a
reliable factor for postoperative hypocalcaemia after
parathyroidectomy for primary hyperparathyroidism.
Therefore, the reduction in i.o. PTH, in addition to ac-
curately predicting whether the surgical removal of
parathyroid tissue was complete, can therefore iden-
tify patients at low risk for hypocalcaemia, thus pro-
moting an early, safe discharge and helping to avoid
expensive overtreatment with oral calcium and vitamin
D analogue.
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